Transcatheter therapy of structural heart disease is advancing rapidly. Due to the less invasive approach, transcatheter techniques have replaced surgery as the standard procedure for atrial septal defect and patent foramen ovale closure.

Evolving interventional techniques allow treatment of paravalvular leaks, ventricular septal defects and valve replacement, especially the rapid evolution and newer indications for transcatheter aortic valve replacement (TAVR).

Related Articles


VEGF-C and Cardiovascular Mortality in Patients Undergoing Drug-eluting…

Takashi Unoki, Shuichi Ura, Daisuke Takagi,

Citation: European Cardiology Review 2018;13(2):124.

Featuring: Dr Patrick Serruys

Patrick W Serruys,

Citation: European Cardiology Review 2018;13(1):80–2.

Haemodynamics of Coronary Artery Stenoses

Valérie E Stegehuis, Gilbert WM Wijntjens, Tadashi Murai,

Citation: European Cardiology Review 2018;13(1):46–53.

The Newest Generation of Drug-eluting Stents and Beyond

Dae-Hyun Lee, José M de la Torre Hernández,

Citation: European Cardiology Review 2018;13(1):54–9.